The new and promising therapy "antigenic"
The therapy is based on the formation of triple helices of DNA and light energy to silence gene activity
The antigen is an innovative therapy treatment strategy that involves the use of DNA-based drugs to precisely locate the light energy on a target gene, thereby shutting down its activity.
A recent review of published Oligonucleotides, a peer-reviewed journal published by Mary Ann Liebert, Inc. of New Rochelle (New York), analyzes the opportunities and challenges for the clinical application of this new approach through modulation of DNA photo-activation. The review can be viewed for free at segnente links (Site-Specific DNA Photocleavage by Oligonucleotide Conjugates and Photomodulation)
Eylon Yavin, and Kolevzon Netanel, of The Hebrew University of Jerusalem (Israel), in their article describing the mechanism that undergirds antigen and development of drugs based on TFO (which stands for Triple Forming Oligonucleotide), capable of inhibiting the expression gene in a highly targeted and selective.
The TFO are in fact oligonucleotides (synthetic) capable of forming a triple helix, breaking into the major groove of the double helix and creating Hoogsteen-type hydrogen bonds with the purines of the Watson-Crick base pairs than : Unlike antisense therapies already exist, that target RNA, then therapy targeting antigen directly to a DNA sequence.
Attaching a photoreactive agent all'oligonucleotide TFO, and providing light energy to the site of attack on the genome, the drug (light sensitive) is activated and triggers a reaction cut or cross-linking DNA damage to the genome, photo- induced and site-specific, will have the effect of gene silencing.
"Many obstacles lie ahead before this strategy can be applied clinically," the authors warn. In any case, if the therapy will prove antigenic actually valid "many currently incurable diseases that are treatable with poor results or otherwise, could be potential applications of this kind of approach," they conclude.
"This is a clever and potentially very effective approach for regulating targeted gene expression," said Jhon Smith, PhD, co-editor of Oligonucleotides and Professor at the Department of Molecular Biology, Beckman Research Institute (California)







Last comments
◊ Daisy @ OCD: a study in 2007 revealed a possible hereditary factor :
◊ Daisy @ OCD: a study in 2007 revealed a possible hereditary factor :
◊ Colaiacovo Moreno @ The bacteria have an acquired immune system :
◊ paul @ Uncovered genes for the synthesis of codeine and morphine in the opium poppy :
◊ Pedrito @ Uncovered genes for the synthesis of codeine and morphine in the opium poppy :